{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:25:46Z","timestamp":1792027546275,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41390-024-03670-x","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T16:02:03Z","timestamp":1729872123000},"page":"1958-1965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Point-of-care procalcitonin trends in suspected neonatal late-onset infection: a prospective observational study"],"prefix":"10.1038","volume":"97","author":[{"given":"Sean J.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Drew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Foran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"3670_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41372-019-0363-4","volume":"39","author":"S Eschborn","year":"2019","unstructured":"Eschborn, S. & Weitkamp, J. H. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis. J. Perinatol. 39, 893\u2013903 (2019).","journal-title":"J. Perinatol."},{"key":"3670_CR2","doi-asserted-by":"publisher","unstructured":"Prkno A., Wacker C., Brunkhorst F. M., Schlattmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock - a systematic review and meta-analysis. Crit. Care. 2013;17. https:\/\/doi.org\/10.1186\/cc13157","DOI":"10.1186\/cc13157"},{"key":"3670_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00134-011-2174-8","volume":"37","author":"EK Vouloumanou","year":"2011","unstructured":"Vouloumanou, E. K., Plessa, E., Karageorgopoulos, D. E., Mantadakis, E. & Falagas, M. E. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med. 37, 747\u2013762 (2011).","journal-title":"Intensive Care Med."},{"key":"3670_CR4","doi-asserted-by":"crossref","unstructured":"Simon L., Gauvin F., Amre D. K., Saint-Louis P., Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin. Infect. Dis. 2004;39. http:\/\/cid.oxfordjournals.org\/.","DOI":"10.1086\/421997"},{"key":"3670_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1473-3099(04)01146-6","volume":"4","author":"A van Rossum","year":"2004","unstructured":"van Rossum, A., Wulkan, R. & Oudesluys-Murphy, A. Procalcitonin as an early marker of infection inneonates and children. Lancet Infect. Dis. 4, 620\u2013630, http:\/\/infection.thelancet.com (2004).","journal-title":"Lancet Infect. Dis."},{"key":"3670_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jamapediatrics.2015.3210","volume":"170","author":"K Milcent","year":"2016","unstructured":"Milcent, K. et al. Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr. 170, 62\u201369 (2016).","journal-title":"JAMA Pediatr."},{"key":"3670_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/00365540701466181","volume":"39","author":"B Isidor","year":"2007","unstructured":"Isidor, B. et al. The use of procalcitonin in the diagnosis of late-onset infection in neonatal intensive care unit patients. Scand. J. Infect. Dis. 39, 1063\u20131066 (2007).","journal-title":"Scand. J. Infect. Dis."},{"key":"3670_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3947\/ic.2019.51.3.263","volume":"51","author":"A So-Ngern","year":"2019","unstructured":"So-Ngern, A. et al. Prognostic value of serum procalcitonin level for the diagnosis of bacterial infections in critically-ill patients. Infect. Chemother. 51, 263\u2013273 (2019).","journal-title":"Infect. Chemother."},{"key":"3670_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/CCM.0000000000002321","volume":"45","author":"P Schuetz","year":"2017","unstructured":"Schuetz, P. et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin monitoring SEpsis (MOSES) Study. Crit. Care Med 45, 781\u2013789 (2017).","journal-title":"Crit. Care Med"},{"key":"3670_CR10","doi-asserted-by":"publisher","first-page":"e2021052228","DOI":"10.1542\/peds.2021-052228","volume":"148","author":"RH Pantell","year":"2021","unstructured":"Pantell, R. H. et al. Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics 148, e2021052228 (2021).","journal-title":"Pediatrics"},{"key":"3670_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1586\/eri.10.25","volume":"8","author":"P Schuetz","year":"2010","unstructured":"Schuetz, P., Albrich, W., Christ-Crain, M., Chastre, J. & Mueller, B. Procalcitonin for guidance of antibiotic therapy. Expert Rev. Anti Infect. Ther. 8, 575\u2013587 (2010).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"3670_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma, L. et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375, 463\u2013474 (2010).","journal-title":"Lancet"},{"key":"3670_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong, E. et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: A randomised, controlled, open-label trial. Lancet Infect. Dis. 16, 819\u2013827 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"3670_CR14","doi-asserted-by":"publisher","unstructured":"Mewes J. C. et al. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis. PLoS ONE. 2019;14. https:\/\/doi.org\/10.1371\/journal.pone.0214222","DOI":"10.1371\/journal.pone.0214222"},{"key":"3670_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(17)31444-7","volume":"390","author":"M Stocker","year":"2017","unstructured":"Stocker, M. et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet 390, 871\u2013881 (2017).","journal-title":"Lancet"},{"key":"3670_CR16","doi-asserted-by":"publisher","unstructured":"Prusakov P. et al. A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study. eClinicalMedicine. 2021;32. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100727","DOI":"10.1016\/j.eclinm.2021.100727"},{"key":"3670_CR17","doi-asserted-by":"publisher","unstructured":"Schulman J., Dimand R. J., Lee H. C., Duenas G. V., Bennett M. V. Neonatal intensive care unit antibiotic use. Pediatrics. 2015;135. https:\/\/doi.org\/10.1542\/peds.2014-3409","DOI":"10.1542\/peds.2014-3409"},{"key":"3670_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/archdischild-2020-320664","volume":"106","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay, S. et al. Neurodevelopmental outcomes following neonatal late-onset sepsis and blood culture-negative conditions. Arch. Dis. Child Fetal Neonatal Ed. 106, 467\u2013473 (2021).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"3670_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/jp.2011.39","volume":"31","author":"DD Wirtschafter","year":"2011","unstructured":"Wirtschafter, D. D. et al. Antibiotic use for presumed neonatally acquired infections far exceeds that for central line-associated blood stream infections: an exploratory critique. J. Perinatol. 31, 514\u2013518 (2011).","journal-title":"J. Perinatol."},{"key":"3670_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1053\/j.semperi.2012.06.005","volume":"36","author":"S Patel","year":"2012","unstructured":"Patel, S. & Saiman, L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin. Perinatol. 36, 431\u2013436 (2012).","journal-title":"Semin. Perinatol."},{"key":"3670_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/1573396315666190118101953","volume":"15","author":"D Gkentzi","year":"2019","unstructured":"Gkentzi, D. & Dimitriou, G. Antimicrobial stewardship in the neonatal intensive care unit: an update. Curr. Pediatr. Rev. 15, 47\u201352 (2019).","journal-title":"Curr. Pediatr. Rev."},{"key":"3670_CR22","unstructured":"NICE. Antimicrobial Stewardship: Systems and Processes for Effective Antimicrobial Medicine Use. 2015. http:\/\/www.nice.org.uk\/guidance\/NG15."},{"key":"3670_CR23","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam, T. F. et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin. Infect. Dis. 62, e51\u2013e77 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"3670_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/archdischild-2019-318026","volume":"105","author":"AR Araujo Da Silva","year":"2020","unstructured":"Araujo Da Silva, A. R. et al. Effectiveness of antimicrobial stewardship programmes in neonatology: A systematic review. Arch. Dis. Child 105, 563\u2013568 (2020).","journal-title":"Arch. Dis. Child"},{"key":"3670_CR25","doi-asserted-by":"publisher","unstructured":"ThermoFisher. B \u00b7 R \u00b7 A \u00b7 H \u00b7 M \u00b7 S PCT Direct Reader Datasheet. 2018. https:\/\/doi.org\/10.1016\/j.clinmicnews.2017.08.004","DOI":"10.1016\/j.clinmicnews.2017.08.004"},{"key":"3670_CR26","unstructured":"Velly L. et al. Validation of B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S PCT direct, a new sensitive point-of-care device for rapid measurement of procalcitonin. In Proc. International Symposium of SICEM. 2019;9. https:\/\/isicem.esn.eu\/posters_listing\/see_poster\/372\/2019\/page_2."},{"key":"3670_CR27","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelinesfor ATC Classification and DDD Assignment. (Norwegian Institute for Public Health, 2023)."},{"key":"3670_CR28","unstructured":"CDC. Core Elements of Hospital Antibiotic Stewardship Programs. (US Department of Health and Human Services, CDC, 2014). http:\/\/www.cdc.gov\/getsmart\/healthcare\/."},{"key":"3670_CR29","doi-asserted-by":"publisher","first-page":"vi50","DOI":"10.1093\/jac\/dky118","volume":"73","author":"MS Beni\u0107","year":"2018","unstructured":"Beni\u0107, M. S. et al. Metrics for quantifying antibiotic use in the hospital setting: Results from a systematic review and international multidisciplinary consensus procedure. J. Antimicrob. Chemother. 73, vi50\u2013vi58 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"3670_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1542\/peds.2004-1680","volume":"115","author":"JA Widness","year":"2005","unstructured":"Widness, J. A. et al. Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 115, 1299\u20131306 (2005).","journal-title":"Pediatrics"},{"key":"3670_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.jp.7211201","volume":"25","author":"A Madan","year":"2005","unstructured":"Madan, A. et al. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J. Perinatol. 25, 21\u201325 (2005).","journal-title":"J. Perinatol."},{"key":"3670_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40262-014-0147-0","volume":"53","author":"JK Roberts","year":"2014","unstructured":"Roberts, J. K. et al. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. Clin. Pharmacokinet. 53, 581\u2013610 (2014).","journal-title":"Clin. Pharmacokinet."},{"key":"3670_CR33","doi-asserted-by":"crossref","unstructured":"Fuchs, A et al. GentamicinExposure and Sensorineural Hearing Loss in Preterm Infants. PLoS One 11, 1\u201311 (2016).","DOI":"10.1371\/journal.pone.0158806"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03670-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03670-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03670-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T09:32:26Z","timestamp":1748511146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03670-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1038\/s41390-024-03670-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written information leaflets were presented to caregivers of all infants approached for study recruitment. Written consent was obtained prior to recruitment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}